Speaker illustration

Doctor Panagiotis STAFYLAS


Member of:

European Society of Cardiology
Heart Failure Association

Cardiologist/ESH Hypertension Specialist with expertise in Health Technology Assessment (HTA). Graduate of the Medical School of the Aristotle University of Thessaloniki (AUTH, GR), PhD in novel CV risk factors and MSc in Health Care Management. Since 2006 he works as HTA Consultant, Medical Coordinator and Evaluation Leader of European eHealth projects. He holds posts as Affiliated Academic and Research Staff in the Postgraduate Program of Health Management in the Univ. of Macedonia (Thessaloniki, GR) and in the Laboratory of Clinical Pharmacology of the Department of Medicine (AUTH, GR).

Real-world data from the use of ranolazine in patients with stable angina pectoris: the RANGER study

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Coronary artery disease - Pharmacotherapy 3


Transforming the experience for patients living with congestive heart failure: the United4Health project

Event: ESC Congress 2016

Topic: Internet and telemedicine

Session: Cardiac computed tomography/Positron emission tomography/Remote monitoring


Economic evaluation of sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction

Event: ESC Congress 2016

Topic: Psycho-social, economic, cultural, occupational diseases

Session: The wide world of cardiovascular research and practice


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb